|
🐜
|
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
29 auth.
D. Hong,
S. DuBois,
S. Kummar,
A. Farago,
C. Albert,
K. Rohrberg,
Cornelis M. van Tilburg,
R. Nagasubramanian,
J. Berlin,
N. Federman,
L. Mascarenhas,
B. Geoerger,
A. Dowlati,
A. Pappo,
S. Bielack,
...
F. Doz,
R. McDermott,
J. Patel,
R. Schilder,
M. Tahara,
S. Pfister,
O. Witt,
M. Ladanyi,
E. Rudzinski,
S. Nanda,
B. Childs,
T. Laetsch,
D. Hyman,
A. Drilon
|
9 |
2020 |
9
🐜
|
|
🐜
|
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
18 auth.
T. Laetsch,
S. DuBois,
L. Mascarenhas,
B. Turpin,
N. Federman,
C. Albert,
R. Nagasubramanian,
Jessica L. Davis,
E. Rudzinski,
Angela Feraco,
...
Brian B. Tuch,
K. Ebata,
M. Reynolds,
Steve Smith,
S. Cruickshank,
M. Cox,
A. Pappo,
D. Hawkins
|
8 |
2018 |
8
🐜
|
|
🐜
|
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
21 auth.
N. Vitanza,
Adam J. Johnson,
A. Wilson,
Christopher Brown,
J. Yokoyama,
A. Künkele,
Cindy A. Chang,
Stephanie D Rawlings-Rhea,
Wenjun Huang,
K. Seidel,
...
C. Albert,
N. Pinto,
J. Gust,
L. Finn,
J. Ojemann,
Jason Wright,
R. Orentas,
M. Baldwin,
R. Gardner,
M. Jensen,
Julie R. Park
|
7 |
2021 |
7
🐜
|
|
🐜
|
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas
15 auth.
S. DuBois,
T. Laetsch,
N. Federman,
B. Turpin,
C. Albert,
R. Nagasubramanian,
Megan E Anderson,
Jessica L. Davis,
H. Qamoos,
M. Reynolds,
...
S. Cruickshank,
M. Cox,
D. Hawkins,
L. Mascarenhas,
A. Pappo
|
6 |
2018 |
6
🐜
|
|
🐜
|
Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors
17 auth.
Jessica L. Davis,
C. Lockwood,
B. Stohr,
C. Boecking,
A. Al-Ibraheemi,
S. DuBois,
S. Vargas,
J. Black,
M. Cox,
M. Luquette,
...
B. Turpin,
S. Szabo,
T. Laetsch,
C. Albert,
D. Parham,
D. Hawkins,
E. Rudzinski
|
6 |
2019 |
6
🐜
|
|
🐜
|
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
39 auth.
N. Vitanza,
A. Wilson,
Wenjun Huang,
K. Seidel,
Christopher Brown,
Joshua A Gustafson,
J. Yokoyama,
Adam J. Johnson,
Blake A Baxter,
R. Koning,
Aquene N. Reid,
Michael Meechan,
M. Biery,
Carrie Myers,
Stephanie D Rawlings-Rhea,
...
C. Albert,
S. Browd,
J. Hauptman,
Amy Lee,
J. Ojemann,
M. Berens,
Matthew D. Dun,
J. Foster,
Erin E. Crotty,
S. Leary,
B. Cole,
Francisco A Perez,
J. Wright,
R. Orentas,
Tony Chour,
E. Newell,
Jeffrey R. Whiteaker,
Lei Zhao,
A. Paulovich,
N. Pinto,
J. Gust,
R. Gardner,
M. Jensen,
Julie R. Park
|
6 |
2022 |
6
🐜
|
|
🐬
|
Infantile NTRK-associated Mesenchymal Tumors
Jessica L. Davis,
C. Lockwood,
C. Albert,
K. Tsuchiya,
D. Hawkins,
E. Rudzinski
|
6 |
2018 |
6
🐬
|
|
🐜
|
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
15 auth.
Xin Huang,
Haein Park,
J. Greene,
James Pao,
Erin Mulvey,
S. Zhou,
C. Albert,
F. Moy,
D. Sachdev,
D. Yee,
...
C. Rader,
C. Hamby,
D. Loeb,
M. Cairo,
Xianzheng Zhou
|
6 |
2015 |
6
🐜
|
|
🦁
|
TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.
C. Albert,
Jessica L. Davis,
N. Federman,
M. Casanova,
T. Laetsch
|
6 |
2019 |
6
🦁
|
|
🐬
|
Hearing Loss in Pediatric Oncology Patients Receiving Carboplatin-containing Regimens
J. Dean,
Susan S. Hayashi,
C. Albert,
A. King,
R. Karzon,
R. Hayashi
|
6 |
2008 |
6
🐬
|
